Skip to main content
Disease Markers logoLink to Disease Markers
. 2018 Jul 19;2018:3714684. doi: 10.1155/2018/3714684

Corrigendum to “Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications”

A Quintanal-Villalonga 1,2, Luis Paz-Ares 1,2,3, Irene Ferrer 1,2, S Molina-Pinelo 1,2,
PMCID: PMC6079511  PMID: 30116404

In the article titled “Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications” [1], there was a missing affiliation for the second author. The corrected authors' list and affiliations are shown above.

References

  • 1.Quintanal-Villalonga A., Paz-Ares L., Ferrer I., Molina-Pinelo S. Tyrosine kinase receptor landscape in lung cancer: therapeutical implications. Disease Markers. 2016;2016:14. doi: 10.1155/2016/9214056.9214056 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Disease Markers are provided here courtesy of Wiley

RESOURCES